相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells
Min-Bin Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib
Preetesh Jain et al.
BLOOD (2015)
Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia
Line Nederby et al.
LEUKEMIA & LYMPHOMA (2015)
Decreased deformability of lymphocytes in chronic lymphocytic leukemia
Yi Zheng et al.
SCIENTIFIC REPORTS (2015)
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study
Guillaume Cartron et al.
BLOOD (2014)
Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia
Regina Jitschin et al.
BLOOD (2014)
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Valentin Goede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lysosome: regulator of lipid degradation pathways
Carmine Settembre et al.
TRENDS IN CELL BIOLOGY (2014)
Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
Anthony S. Don et al.
BIOMOLECULES (2014)
Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase
Nikolaj H. T. Petersen et al.
CANCER CELL (2013)
Lysosomal cell death at a glance
Sonja Aits et al.
JOURNAL OF CELL SCIENCE (2013)
Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors
Mahadeo A. Sukhai et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes
M. Hafner Cesen et al.
CELL DEATH & DISEASE (2013)
Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B
J-Y Yoon et al.
BLOOD CANCER JOURNAL (2013)
The mitochondrial permeability transition pore (PTP) - An example of multiple molecular exaptation?
Angelo Vianello et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2012)
The B-cell receptor signaling pathway as a therapeutic target in CLL
Jennifer A. Woyach et al.
BLOOD (2012)
Physiological Roles of the Permeability Transition Pore
Catherine Brenner et al.
CIRCULATION RESEARCH (2012)
Lipids and Lysosomes
Isabelle Hamer et al.
CURRENT DRUG METABOLISM (2012)
Sphingosine mediates TNFα-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells
Chiara Ullio et al.
JOURNAL OF LIPID RESEARCH (2012)
Pterostilbene-Induced Tumor Cytotoxicity: A Lysosomal Membrane Permeabilization-Dependent Mechanism
Salvador Mena et al.
PLOS ONE (2012)
CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101
Margot Jak et al.
BLOOD (2011)
Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies
Waleed Alduaij et al.
BLOOD (2011)
Dysregulation of sphingolipid metabolism in cancer
Lindsay K. Ryland et al.
CANCER BIOLOGY & THERAPY (2011)
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
Albert Gutierrez et al.
BLOOD (2010)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M. Hallek et al.
LANCET (2010)
Membranes in Balance: Mechanisms of Sphingolipid Homeostasis
David K. Breslow et al.
MOLECULAR CELL (2010)
Effects of ceramide and other simple sphingolipids on membrane lateral structure
Felix M. Goni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia
Grzegorz S. Nowakowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation
Marie Stampe Ostenfeld et al.
AUTOPHAGY (2008)
Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2
Nicole Fehrenbacher et al.
CANCER RESEARCH (2008)
Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers
Tatjana Mijatovic et al.
NEOPLASIA (2006)
Effective tumor cell death by σ-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress
MS Ostenfeld et al.
CANCER RESEARCH (2005)
Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression
E Le Scolan et al.
BLOOD (2005)
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
MJ Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis
H Erdal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
US food and drug administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax
A Meyerhoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine
JS Carew et al.
LEUKEMIA (2004)
Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion
P Boya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells
VE Nava et al.
EXPERIMENTAL CELL RESEARCH (2002)
Sphingosine-induced apoptosis is dependent on lysosomal proteases
K Kågedal et al.
BIOCHEMICAL JOURNAL (2001)
Structure and function of sphingolipid- and cholesterol-rich membrane rafts
DA Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
